During the past decade, J. Lewis Research Inc./FirstMed East conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "J. Lewis Research Inc./FirstMed East" #1 sponsor was "BioCryst Pharmaceuticals" with 1 trials, followed by "IBSA Institut Biochimique SA" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Seqirus" with 1 trials sponsored and "Yiling Pharmaceutical Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "J. Lewis Research Inc./FirstMed East" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "J. Lewis Research Inc./FirstMed East" are "Acute, Uncomplicated Human Influenza" (1 trials), "Athletic Injuries" (1 trials), "Avian Influenza" (1 trials), "Influenza A" (1 trials) and "Influenza, Human" (1 trials). Many other conditions were trialed in "J. Lewis Research Inc./FirstMed East" in a lesser frequency.

Most popular intervention types in "J. Lewis Research Inc./FirstMed East" are "Drug" (4 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Diclofenac hydroxyethylpyrrolidine" (1 trials), "KT07 Capsule" (1 trials), "Peramivir" (1 trials) and "Pimodivir 600 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "J. Lewis Research Inc./FirstMed East" are 5 trials for "All" genders.

Currently, there are NaN active trials in "J. Lewis Research Inc./FirstMed East". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in J. Lewis Research Inc./FirstMed East, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in J. Lewis Research Inc./FirstMed East, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".